Recherche
Enseignement
Solutions
S'identifier
FR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Laboratory of Virology,
Division of Intramural Research,
Laboratory of Virology, Division of Intramural Research
Thomas Hoenen has not added Biography.
If you are Thomas Hoenen and would like to personalize this page please email our Author Liaison for assistance.
VP40 octamers are essential for Ebola virus replication.
Journal of virology Feb, 2005 | Pubmed ID: 15650213
Ebola virus: unravelling pathogenesis to combat a deadly disease.
Trends in molecular medicine May, 2006 | Pubmed ID: 16616875
Infection of naive target cells with virus-like particles: implications for the function of ebola virus VP24.
Journal of virology Jul, 2006 | Pubmed ID: 16809331
In vitro evaluation of antisense RNA efficacy against filovirus infection, by use of reverse genetics.
The Journal of infectious diseases Nov, 2007 | Pubmed ID: 17940974
Establishment and application of an infectious virus-like particle system for Marburg virus.
The Journal of general virology May, 2010 | Pubmed ID: 20071483
Efficient budding of the tacaribe virus matrix protein z requires the nucleoprotein.
Journal of virology Apr, 2010 | Pubmed ID: 20106925
Tacaribe virus but not junin virus infection induces cytokine release from primary human monocytes and macrophages.
PLoS neglected tropical diseases , 2011 | Pubmed ID: 21572983
Minigenomes, transcription and replication competent virus-like particles and beyond: reverse genetics systems for filoviruses and other negative stranded hemorrhagic fever viruses.
Antiviral research Aug, 2011 | Pubmed ID: 21699921
Genus-specific recruitment of filovirus ribonucleoprotein complexes into budding particles.
The Journal of general virology Dec, 2011 | Pubmed ID: 21900424
Ebola virus enters host cells by macropinocytosis and clathrin-mediated endocytosis.
The Journal of infectious diseases Nov, 2011 | Pubmed ID: 21987776
Current ebola vaccines.
Expert opinion on biological therapy Jul, 2012 | Pubmed ID: 22559078
The Ebola virus glycoprotein contributes to but is not sufficient for virulence in vivo.
PLoS pathogens , 2012 | Pubmed ID: 22876185
Inclusion bodies are a site of ebolavirus replication.
Journal of virology Nov, 2012 | Pubmed ID: 22915810
An upstream open reading frame modulates ebola virus polymerase translation and virus replication.
PLoS pathogens Jan, 2013 | Pubmed ID: 23382680
Phosphorylation of Ebola virus VP30 influences the composition of the viral nucleocapsid complex: impact on viral transcription and replication.
The Journal of biological chemistry Apr, 2013 | Pubmed ID: 23493393
The role of oligomerization for the biological functions of the arenavirus nucleoprotein.
Archives of virology Sep, 2013 | Pubmed ID: 23553456
A novel Ebola virus expressing luciferase allows for rapid and quantitative testing of antivirals.
Antiviral research Sep, 2013 | Pubmed ID: 23751367
Ebola virus RNA editing depends on the primary editing site sequence and an upstream secondary structure.
PLoS pathogens , 2013 | Pubmed ID: 24146620
Virus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNA.
Archives of virology May, 2014 | Pubmed ID: 24190508
Development and application of reporter-expressing mononegaviruses: current challenges and perspectives.
Antiviral research Mar, 2014 | Pubmed ID: 24462694
Ebola virus modulates transforming growth factor β signaling and cellular markers of mesenchyme-like transition in hepatocytes.
Journal of virology Sep, 2014 | Pubmed ID: 24942569
A Novel Life Cycle Modeling System for Ebola Virus Shows a Genome Length-Dependent Role of VP24 in Virus Infectivity.
Journal of virology Sep, 2014 | Pubmed ID: 24965473
Analysis of the highly diverse gene borders in Ebola virus reveals a distinct mechanism of transcriptional regulation.
Journal of virology Aug, 2014 | Pubmed ID: 25142600
Reverse genetics systems as tools for the development of novel therapies against filoviruses.
Expert review of anti-infective therapy Oct, 2014 | Pubmed ID: 25169588
Lifecycle modelling systems support inosine monophosphate dehydrogenase (IMPDH) as a pro-viral factor and antiviral target for New World arenaviruses.
Antiviral research Sep, 2018 | Pubmed ID: 30031760
A genome-wide siRNA screen identifies a druggable host pathway essential for the Ebola virus life cycle.
Genome medicine 08, 2018 | Pubmed ID: 30081931
Assessing cross-reactivity of Junín virus-directed neutralizing antibodies.
Antiviral research Mar, 2019 | Pubmed ID: 30668977
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Friedrich-Loeffler-Institut
Thomas Hoenen1,
Ari Watt1,
Anita Mora2,
Heinz Feldmann1
1Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health,
2Research Technology Branch, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Andreas Mueller1,
Kerstin Fischer2,
Roland Suluku3,
Thomas Hoenen1
1Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut,
2Institute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut,
3Department of Animal Science, Njala University
Confidentialité
Conditions d'utilisation
Politiques
Contactez-nous
RECOMMANDER À LA BIBLIOTHÈQUE
NEWSLETTERS JoVE
JoVE Journal
Collections de méthodes
JoVE Encyclopedia of Experiments
Archives
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centre de ressources universitaires
Auteurs
Bibliothécaires
Accès
À PROPOS DE JoVE
Copyright © 2024 MyJoVE Corporation. Tous droits réservés.